A detailed history of Advisor Group Holdings, Inc. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,849 shares of ORMP stock, worth $9,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,849
Previous 3,849 -0.0%
Holding current value
$9,006
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.07 - $2.83 $1,655 - $2,264
-800 Reduced 17.21%
3,849 $9,000
Q1 2024

May 10, 2024

SELL
$2.18 - $3.58 $8,131 - $13,353
-3,730 Reduced 44.52%
4,649 $13,000
Q4 2023

Feb 12, 2024

SELL
$1.71 - $2.57 $19,323 - $29,041
-11,300 Reduced 57.42%
8,379 $19,000
Q3 2023

Nov 13, 2023

BUY
$2.51 - $3.55 $8,634 - $12,212
3,440 Added 21.18%
19,679 $51,000
Q2 2023

Aug 10, 2023

SELL
$2.12 - $4.47 $3,852 - $8,121
-1,817 Reduced 10.06%
16,239 $58,000
Q1 2023

May 12, 2023

SELL
$1.93 - $13.1 $8,497 - $57,679
-4,403 Reduced 19.6%
18,056 $39,000
Q4 2022

Feb 10, 2023

SELL
$5.88 - $12.03 $13,182 - $26,971
-2,242 Reduced 9.08%
22,459 $270,000
Q3 2022

Nov 14, 2022

BUY
$4.6 - $9.91 $25,290 - $54,485
5,498 Added 28.63%
24,701 $161,000
Q2 2022

Aug 10, 2022

BUY
$3.72 - $9.0 $10,598 - $25,641
2,849 Added 17.42%
19,203 $88,000
Q1 2022

May 04, 2022

SELL
$8.19 - $13.89 $9,959 - $16,890
-1,216 Reduced 6.92%
16,354 $137,000
Q3 2021

Nov 05, 2021

BUY
$12.13 - $23.82 $121,081 - $237,771
9,982 Added 131.55%
17,570 $386,000
Q2 2021

Aug 02, 2021

BUY
$8.34 - $14.59 $23,877 - $41,771
2,863 Added 60.59%
7,588 $101,000
Q1 2021

May 13, 2021

BUY
$4.22 - $11.33 $15,719 - $42,204
3,725 Added 372.5%
4,725 $48,000
Q4 2020

Feb 10, 2021

BUY
$2.48 - $4.64 $2,480 - $4,640
1,000 New
1,000 $4,000
Q2 2020

Aug 14, 2020

SELL
$2.87 - $4.12 $2,870 - $4,120
-1,000 Closed
0 $0
Q1 2020

May 18, 2020

BUY
$2.6 - $5.5 $2,600 - $5,500
1,000 New
1,000 $3,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $90.9M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.